03/10/2026
An important post from The Equine Behaviour Vet about the distinction between clinical innovation and animal experimentation, and the questions we should be asking about evidence, risk and uncertainty.
Particularly important, I think, is the emphasis on informed decision-making and meaningful monitoring of outcomes. New or innovative does not necessarily mean evidence-based, and apparent improvement may not in itself tell us whether or not the intervention caused it.
Well worth a read.
When does veterinary innovation become animal experimentation?
This topic has come up in several discussions I’ve had over the past few weeks, and I think it’s an important one.
Advances in clinical care and new treatment options can transform the lives of our horses. But how do we know how well they actually work and, really importantly, whether they are safe?
It’s more complicated than it might initially seem. There are many reasons a horse may improve after treatment that have little to do with the treatment itself.
These include recovery over time (lots of conditions get better despite what we do) fluctuating symptoms, changes in management and changes in how we interact with the horse.
There’s also the placebo effect. Of course we want our horses and patients to get better, but those expectations can influence how we interpret and report what we see. This doesn’t mean anyone is being dishonest but it’s a reason to assess outcomes carefully.
The same scrutiny applies to surgery. An impressive explanation, enthusiastic testimonials or convincing before and after videos do not, on their own, establish effectiveness or safety.
And it’s important to understand that, although safeguarding regulations exist, there is often significant differences in the level of rigour depending upon whether the intervention is classed as an act of veterinary medicine/surgery or clinical research and experimentation.
There are also regulations and ethical principles that guide how we (vets) should weigh up the pros and cons of each treatment option to ensure we are maximising the benefits and minimising any potential harms.
We frequently lack medicines licensed for the particular conditions we treat in horses. This can mean using a medicine outside its authorised use, including one licensed for another condition or species. That can be appropriate, but decisions must follow the applicable prescribing rules, draw on the best available evidence and involve informed discussions with owners.
Owners should understand what is known, what remains uncertain, the alternatives and the potential risks as well as benefits.
We also need structured monitoring of clinical progress and side effects, using objective measures where possible. We should agree what meaningful improvement would look like, when to review treatment and what would prompt us to change or stop it. Suspected adverse reactions should be reported through the appropriate channels.
Please never feel afraid to ask your vet for more information. Asking about evidence, uncertainty and alternatives is part of making an informed decision together.
I’d love to hear your thoughts. What would you want to know before agreeing to a new treatment for your animal? Have you ever felt unclear about the evidence for a treatment offered to your horse, or have you participated in a research trial?